| AstraZeneca Signs US$1.77 B Renal Disease Licensing Pact with CSPC Pharmaceutical Group |
Abstract
pdf
html
|
|
Nikita Negi |
|
| AstraZeneca Signs US$2.1 B Respiratory Disease Licensing Agreement with Sino Biopharmaceutical for TQC3721 |
Abstract
pdf
html
|
|
Nikita Negi |
|
| GSK Expands Oncology Portfolio with US$10.6 B Acquisition of Nuvalent |
Abstract
pdf
html
|
|
Sanya Sekhri |
|
| AbbVie Deepens Immunology Leadership with US$10.9 B Acquisition of Apogee Therapeutics |
Abstract
pdf
html
|
|
Nikita Negi |
|
| Ipsen Expands Rare Disease Portfolio with US$1 B+ Acquisition of Memo Therapeutics |
Abstract
pdf
html
|
|
Naini Anand |
|
| Vertex to Acquire Crinetics Pharmaceuticals for US$10 B |
Abstract
pdf
html
|
|
Ayush Saxena |
|
| Lilly to Acquire AtaiBeckley to Advance Therapies Targeting Resistant Depression and Other Mental Health Conditions for US$3.8 B |
Abstract
pdf
html
|
|
Naini Anand |
|
